← FDA DRUG APPROVALS

FDA ANDA · ANDA074145

GUANFACINE

Sponsor: WATSON LABS

APPLICATION
ANDA074145
TYPE
ANDA
ORIGINAL APPROVAL
1995-10-17
LATEST ACTION
2016-11-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

GUANFACINE HYDROCHLORIDEPrescription
GUANFACINE HYDROCHLORIDE EQ 2MG BASE · TABLET · ORAL
GUANFACINE HYDROCHLORIDEPrescription
GUANFACINE HYDROCHLORIDE EQ 1MG BASE · TABLET · ORAL

Approval history

2016-11-30Labeling · Supplement 21 · standardAP
2003-07-16Labeling · Supplement 9AP
2002-08-05Manufacturing (CMC) · Supplement 8AP
2002-05-21Manufacturing (CMC) · Supplement 6AP
2001-09-27Manufacturing (CMC) · Supplement 3AP
2001-09-05Manufacturing (CMC) · Supplement 5AP
1999-11-10Manufacturing (CMC) · Supplement 2AP
1998-03-18Manufacturing (CMC) · Supplement 1AP
1995-10-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →